DealForma Logo White
  • FEATURES
  • PRICING
  • BLOG
  • SCHEDULE A DEMO
  • SIGN IN
SCHEDULE A DEMO
SIGN IN
August 2023 Top Biopharma Deal: Poseida license option deal with Astellas for P-MUC1C-ALLO1

August 2023 Top Biopharma Deal: Poseida license option deal with Astellas for P-MUC1C-ALLO1

by Chris Dokomajilar | Sep 5, 2023 | Deal of the Month, Partnership Deals

Q2 2023 Review Of R&D Partnerships For Biopharma Therapeutics & Platforms

Q2 2023 Review Of R&D Partnerships For Biopharma Therapeutics & Platforms

by Chris Dokomajilar | Aug 14, 2023 | Analysis, Partnership Deals

Biopharma licensing activity in Q2 2023 was the lowest since 2019. Development and commercialization deals for the quarter came in at 110 deals for a total announced value of $28.2 billion with $1.2 billion in total upfront cash and equity. There were notable deals...
Healthcare & Life Sciences Sector: Quarterly Overview

Healthcare & Life Sciences Sector: Quarterly Overview

by Chris Dokomajilar | Aug 1, 2023 | Analysis, Funding, M&A, Partnership Deals

The biopharmaceutical industry outlook for the new quarter remains dynamic and promising, characterized by significant deals in the first half. Galderma’s private placement of $1 billion aims to strengthen its dermatology position and leverage its integrated...
July 2023 Top Biopharma Deal: Alnylam co-development and co-commercialization deal with Roche for zilebesiran

July 2023 Top Biopharma Deal: Alnylam co-development and co-commercialization deal with Roche for zilebesiran

by Chris Dokomajilar | Aug 1, 2023 | Deal of the Month, Partnership Deals

R&D Partnerships by TA – Autoimmune

R&D Partnerships by TA – Autoimmune

by Chris Dokomajilar | Jun 15, 2023 | Analysis, Partnership Deals

So far, 2023 has witnessed a mixed landscape for R&D partnerships in the autoimmune sector. While there were notable activities and collaborations, there was a decline in the number of deals and the overall value compared to previous years. This suggests a...
R&D Partnerships – Medtech – Q1 2023

R&D Partnerships – Medtech – Q1 2023

by Chris Dokomajilar | Jun 8, 2023 | Analysis, Partnership Deals

Medtech R&D partnerships play a significant role in driving innovation and advancements in healthcare. Medtech’s various focus areas, such as medical devices, digital health solutions, and wearable technologies, saw active collaboration and investment, but...
« Older Entries

Categories

  • Analysis
  • Deal of the Month
  • Funding
  • M&A
  • Partnership Deals
  • Product Support and Tips
  • Updates

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
DealForma Logo Blue

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Database
  • Features
  • Support
  • Pricing
Comparisons
  • Alternative to Evaluate Pharma
  • Alternative to BioSciDB
  • Alternative to Clarivate Cortellis
  • Alternative to BioCentury BCIQ
  • Alternative to PitchBook
  • Other Database Alternatives
Company
  • About Us
  • Analysis / Blog
  • Contact Us
  • Follow
  • Follow

Made in San Mateo, CA and around the world    support@dealforma.com   (650) 353-9363

Terms
Privacy
Copyright © 2023 DealForma